SEMA4A and demyelinating disease: Using a Sema4A-specific ELISA, we determined that Sema4A levels are higher in individuals with HIV infection (53.72 ± 14.37 ng/mL) compared with HIV-seronegative, control individuals without known demyelinating disease.